SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-009718
Filing Date
2023-03-27
Accepted
2023-03-27 16:05:30
Documents
1
Period of Report
2023-03-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3379
  Complete submission text file 0000899243-23-009718.txt   4962
Mailing Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142 617-410-4650
Cullinan Oncology, Inc. (Issuer) CIK: 0001789972 (see all company filings)

IRS No.: 813867811 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CULLINAN MANAGEMENT, INC. ONE MAIN STREET, SUTIE 520 CAMBRIDGE MA 02142
Business Address
Trigilio Jeffrey (Reporting) CIK: 0001838671 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39856 | Film No.: 23764558